FDA Inspection
Bajaj Medical, LLCBajaj Medical, LLC – FDA Inspection, Dec 4, 2024
Record Details
This FDA Inspection record concerns Bajaj Medical, LLC, with an inspection on December 4, 2024, issued by the Chicago District Office, covering human drugs.
View Company Profile
ID · 012bea19-fa01-4b79-9271-4c70d3dcaf6d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1255693
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
FDA Citations
1- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bajaj Medical, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 25, 2025 | VAI | Chicago District Office | Drug Quality Assurance |
| October 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 16, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bajaj Medical, LLC
- FDA Inspection 1279946 - 2025-08-25
- FDA Inspection 1105167 - 2019-10-01
- FDA Inspection 946000 - 2015-10-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.